India has a rich diversity of languages, with over 1,600 languages spoken across the nation. Sanskrit, an ancient, classical sacerdotal language of India, has a rich morphosyntactic influence on Bhadarwahi. This study aims to analyze the key linguistic similarities and differences between Bhadarwahi and Sanskrit, elaborating on vocabulary, origin, and word order while also emphasizing the potential contributions of Sanskrit to Bhadarwahi. The paper uses a comparative analysis method, and investigates word order, revealing how Bhadarwahi and Sanskrit use the same word order structures such as subject-object-verb (SOV). This study expands our understanding of linguistic diversity, as languages continually shape and are shaped by one another.
SUBJECT CATEGORY: MEDICINE | Oct. 31, 2024
Oral Suspension as Versatile Galenic Formulation in Pediatry
Luisetto M, Almukthar N, Edbey K, Mashori G.R, Fiazza C, Dona’ l, Cabianca L, Latyshev O
Page no 202-213 |
DOI: https://doi.org/10.36348/sb.2024.v10i08.002
In the last years increased the prescription of drugs in pediatry as pharmaceutical form of oral suspension. The same in commerce there are various producer that provide specific ready for use excipeints to make more easy to prepare OS in the galenic laboratory. Aim of this work is to verify the advantages of this pharmaceutical form to cover pediatrics dosages vs other form and also to overcome shortcomings of some crucial registered drugs. In this work are reported also scientific literature relates some ready for use product as bases- veicle for suspension and some formulations of interest.
SUBJECT CATEGORY: PHARMACEUTICAL TECHNOLOGY | Oct. 31, 2024
Development of Plantain and Cocoyam Bread and Assessment of Its Nutritional Value to the Elderly
Ndidi F. Ezeibe, Nwabueze Robinson
Page no 214-218 |
DOI: https://doi.org/10.36348/sb.2024.v10i08.003
Cakes were produced from the substitution levels of cocoyam and plantain Nour blends (0-100% and 0-70%), respectively and enriched with 0-30% levels of Bambara groundnut protein concentrate (BGPC) Quality characteristics of the resultant product were analysed to ascertain its sensory. physical and chemical properties Acceptable cakes were produced from 70% wheat flour, 20% plantain flour and 10% BGPC with regards to colour which compared favourably with sample A (100% WF) except F and G samples which differs significantly with other samples The texture of the cakes was also acceptable but F and G samples (6.5 and 6.4), respectively shows significant difference (p <0.05) compared to others. The taste and overall acceptability were not significantly different it all levels of BGPC enrichment compared to sample A. There was no significant difference (p > 0:05) in all the samples in terms of the height except sample B with the value of 2.5cm. Highest weight of 194 2g was observed for sample B which was significantly different (p<0.05) compared to other samples Increase in BGPC further improved the volume and specific volume of the cake to 524cm3 and 3. 19cm3/100g (sample G), respectively A reduction in the values of carbohydrate, moisture and energy content of the cakes were observed at increased levels of protein concentrate Protein content of the cakes was observed to improve progressively at increasing levels of enrichment and showed significant differences up to sample D (10.4%) while the highest protein value was reported at sample G (13.2%) with 30% protein concentrate. This confirms that the developed cakes have a better nutritional value than the control and could be used to combat protein energy malnutrition.
SUBJECT CATEGORY: GASTROENTEROLOGY | Oct. 31, 2024
Budesonide –Oral Galenic Formulations for Chron Disease
Luisetto, M, Mashori, G. R, Mashori, G. R, Cabianca, L, Latyshev, O
Page no 219-226 |
DOI: https://doi.org/10.36348/sb.2024.v10i08.004
Aim of this work is to verify the farmaceutical form of oral Budesonide compounded used in Chron’s disease: capsules delay release or oral suspension. In particular way the kinds of excipients or bases-veicle used in the galenic pharmacy. The therapeutic need require a release of the API in delayed release. The Budesonide show low systemic impacts due by its hepatic methabolism vs a tocipal effect useful in this pathology. Some formulation provided by various pharmacy are reported as well as new technology like the 3D-PRINTING systems for colonic targeting tablets.